Thursday

21st Jan 2021

Coronavirus

EU wants to pay in advance for promising vaccines

  • In an effort to find a successful vaccine fast, companies are building up production and trying promising drugs at the same time (Photo: Hospital Clínic)

The EU Commission wants member states' support to pay some of the costs upfront for companies working on potential Covid-19 vaccines and secure doses for European citizens.

Under its "vaccine strategy" to be presented next Wednesday (17 June), the EU executive plans to sign contracts with pharmaceutical companies working on possible vaccines on behalf of the 27 member states.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

EU health ministers will discuss the plans with the commission when they meet on Friday (12 June).

The commission argued it makes more sense for EU countries to negotiate together rather than in parallel and possibly in competition with one another with firms to secure a vaccine and supply for citizens.

The commission and EU countries' experts would negotiate with companies and agree in an advance payment that firms could use to upgrade their production facilities and look for raw material, even as trials for potential vaccines are still ongoing.

In preliminary talks, companies have told the commission they need public authorities to help "derisk the investment" in potential vaccines.

In order to secure a successful vaccine fast, companies need to build capacities at the same time as they put potential vaccines through trials that eventually might or might not be successful.

The EU would help with those costs, and take that risk, in exchange for commitment from these companies to provide the vaccine to the EU when it is successful and ready.

"We provide funding, they invest, prepare the vaccine, and if successful, they give it to us, with the risk that some of of the potential vaccines we invest in won't work," a commission official said.

Ultimately, the member states would be buying the vaccines and governments would decide on who gets access to the drug first, with most likely health care and frontline workers getting vaccinated first.

The commission aims at signing contracts with several companies to hedge bets. For now it has set aside €2.7bn from the EU budget for advanced payments.

'Contract, not subsidy'

"We are not talking here about subsidies to companies, we are talking about contracting for the vaccine, reflecting the cost of producing it," the commission official said.

The executive will be looking at companies that have the potential to develop the drug fast, whose vaccine has already entered the clinical trials phase or is very close to that.

The commission is also looking for companies that have a very strong production capacity in Europe. "We look at production facility, not the nationality of company," the commission official added.

The official said the EU needs to secure around 300-600 million doses of the vaccine depending on how many doses are needed per person for immunisation.

The EU executive also proposes temporarily lifting the requirement to have an environmental risk assessment on possible GMOs used to develop the vaccine, because it would delay the process. But the member states and the EU parliament need to agree to this move.

Recently, an "alliance" between Germany, France, Italy and the Netherlands was also forged to fund and secure vaccine for Europeans.

The commission official said they are not competing with the alliance and, within a matter of days, they will work out how to combine their efforts.

Once member states agree to task the commission with negotiating with companies, the EU countries could not negotiate themselves with the same companies, but could contract firms that have not signed agreements with the EU executive.

Commission plans strategy to 'maximise' vaccine access

The EU Commission plans a vaccine stategy to make sure all citizens have access to it once it is ready, while it is also seeking to negotiate with pharmaceutical companies on securing the vaccine.

EU launches funding drive for Covid-19 vaccine

The European Commission launches on Monday an initiative to raise €7.5bn to speed up the development of vaccines, treatment and testing capacity, ensuring that is equally "available to everyone and at affordable prices" and avoiding nationalisms.

EU still divided on recovery but Denmark relaxes position

Ahead of EU leaders' first online discussion on the EU recovery and budget plans, EU countries remain divided on the key issues in the economic package. They will need to hammer them out in person in July.

EU Commission ready to play bigger role in health sector

The public health crisis caused by the coronavirus in member states has pushed the European Commission to play a more active in the field of health, especially funding the development of an effective Covid-19 vaccine.

How EU aims - hopefully - to secure vaccine by end of 2020

The European Commission hopes to have 30m doses of AstraZeneca's potential coronavirus vaccine before the end of this year, to be distributed on a population-based pro-rata basis among the 27 EU countries - until the 300m doses negotiated arrive.

News in Brief

  1. Hungary gives initial ok for UK and Russian vaccines
  2. Russia files for Sputnik vaccine registration in EU
  3. Destruction and three deaths in Madrid explosion
  4. Liberals kick out Lithuanian MEP for homophobic jibes
  5. Air pollution killing thousands of Europeans a year
  6. First migrant tragedy of 2021 claims 43 lives
  7. Train revival needed to meet EU climate goals
  8. NGOs shame Monaco for persecuting UK whistleblower

EU seeks more health powers after dubious Covid-19 response

After the lack of coordination evidenced during the first months of the Covid-19 pandemic, the European Commission put forward a set of proposals to strengthen the preparedness of members states in cross-border health threats.

Column

BioNTech: Stop talking about their 'migration background'

I understand that the German-Turkish community - often subjected to condescension in Germany - celebrated the story. Uğur Şahin and Özlem Türecki represent scientific excellence and business success at the highest level.

Stakeholders' Highlights

  1. UNESDAEU Code of Conduct can showcase PPPs delivering healthier more sustainable society
  2. CESIKlaus Heeger and Romain Wolff re-elected Secretary General and President of independent trade unions in Europe (CESI)
  3. Nordic Council of MinistersWomen benefit in the digitalised labour market
  4. Nordic Council of MinistersReport: The prevalence of men who use internet forums characterised by misogyny
  5. Nordic Council of MinistersJoin the Nordic climate debate on 17 November!
  6. UNESDAMaking healthier diets the easy choice

Latest News

  1. US returns to climate deal and WHO, as EU 'rejoices'
  2. Big tech: From Trump's best friend to censorship machine?
  3. Turkish minister in Brussels to discuss new migrant deal
  4. EU leaders to discuss vaccine certificates
  5. On Erdoğan and Europe's 'ontological' choice
  6. MEPs call to halt Russia pipeline over Navalny arrest
  7. EU targets vaccinating 70% of adults by summer
  8. Portugal pushes to start delayed 'future EU' conference

Join EUobserver

Support quality EU news

Join us